Table 1

Univariate comparison of high-volume centers performing intra-arterial stroke therapies with lower volume centers

VariableHigh-volume center (N=280) N (%)Lower volume center (N=162) N (%)p Value
Demographics
 Age (mean±SD)65±1567±140.09
 Women133 (48)91 (56)0.09
 Hypertension206 (74)125 (77)0.49
 Atrial fibrillation102 (43)54 (33)0.47
 Diabetes mellitus65 (23)41 (25)0.64
 Mean±SD NIHSS17±518±60.53
Location of thrombus
 M1 MCA194 (69)114 (70)0.91
 M2 MCA32 (11)22 (14)0.34
 Carotid terminus49 (18)29 (18)0.89
 Tandem occlusion35 (13)12 (7)0.11
Clinical variables
 Intravenous t-PA administered134 (48)61 (38)0.04
 Outside hospital transfer180 (64)50 (31)0.0001
 Successful reperfusion212 (76)92 (57)0.001
 Good clinical outcome (N=390)109/236 (46)49/154 (32)0.009
 Symptomatic hemorrhage21 (8)12 (7)0.65
 Asymptomatic hemorrhage82 (29)57 (35)0.12
 Median (IQR) infarct volume (cm3) (N=352 patients)41 (20–106)57 (27–140)0.03
Timings for each step
 Mean±SD time from symptom onset to CT acquisition (min)317±174194±1350.19
 Mean±SD CT acquisition to groin puncture (min)89±64153±820.002
 Mean±SD groin puncture to guide catheter run (min)12±728±270.001
 Mean±SD first injection to microcatheter placement (min)20±1632±280.001
 Mean±SD total procedure time (min)92±47125±620.003
  • MCA, middle cerebral artery; NIHSS, NIH Stroke Scale; t-PA, tissue plasminogen activator.